CDC27 and neoplasm: Various studies have reported the CDC27 mutation rate in CDCs as over 5%, and this mutation is known to be associated with tumor proliferation and progression in CRCs.4 In our study, this somatic mutation was determined with the highest rate of 46.6%, which suggests regional differences.